Related Experiment Videos
Efficacy at G-protein-coupled receptors
1GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, USA. tpk1348@gsk.com
Nature Reviews. Drug Discovery
|July 18, 2002
Summary
Ligands binding to receptors can have therapeutic uses beyond blocking or activating them. Broader testing of ligand affinity and efficacy is recommended to uncover novel drug activities.
Area of Science:
- Pharmacology
- Drug Discovery
- Receptor Theory
Background:
- Current drug discovery focuses on ligands that block or activate receptors.
- Ligands affecting receptors in other ways also hold therapeutic potential.
- The relationship between ligand affinity and receptor efficacy is complex.
Purpose of the Study:
- To review the relationship between ligand affinity and receptor efficacy.
- To highlight the therapeutic potential of ligands with nuanced receptor interactions.
- To advocate for broader testing of ligand binding properties.
Main Methods:
- Literature review of receptor-ligand interactions.
- Analysis of the concept of ligand efficacy.
- Discussion of drug discovery paradigms.
Main Results:
- Ligand affinity does not solely predict physiological response.
- Ligands can modulate receptor function without blocking or activating.
- Efficacy is a probabilistic outcome of ligand-receptor binding.
Conclusions:
- Ligands with affinity for receptors should be tested for a wider range of efficacies.
- This broader testing can reveal previously undetected therapeutic activities.
- Rethinking drug discovery approaches can unlock new therapeutic avenues.